Publication | Closed Access

A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies

Hematological MalignancyOncologyBone Marrow FailurePhase I/ii StudyHigh-dose CyclophosphamideMedicineMalignant Blood DisorderImmunologyHematologyMyeloid NeoplasiaAutologous Bone MarrowMyelopoiesisRadiation OncologyImmunotherapyCell TransplantationCancer ResearchHealth Sciences